Co-Activation
Proposal
Building on a shared commitment to emerging manager performance, research-driven capital allocation, and bias reduction across institutional investing.
emerging managers
Two Organizations, One Thesis
Colibrí Institute and Illumen Capital operate from a shared conviction: emerging managers are systematically excluded from institutional capital flows, and that exclusion carries a measurable performance cost.
Colibrí Institute
Independent nonprofit research organization producing open-access, empirical, venture-specific research. Our flagship white paper, "Why Emerging Venture Capital Managers Matter," analyzed 2,471 U.S. VC funds (2000 to 2024) and documented a 7.2 percentage point IRR outperformance by emerging managers, translating to $72M in foregone value per $100M allocated through consensus-driven selection.
Illumen Capital
Research-backed fund of funds investing in the next generation of venture and private equity managers. Illumen combines investment capital with IllumenIQ, a proprietary bias-reduction platform developed alongside Stanford SPARQ, to help portfolio managers expand their investable landscape and unlock stronger returns by reducing bias in allocation decisions.
Where Our Work Converges
Both organizations lead with research, center performance over compliance narratives, and are building infrastructure to shift how institutional capital reaches emerging managers.
Research-first approach to emerging managers
Illumen was built on PNAS-published research demonstrating racial bias in investor decision-making. Colibrí Institute launched with empirical evidence that emerging managers outperform. Both organizations lead with data rather than narrative alone.
Performance framing over compliance framing
Neither organization positions emerging manager allocation as a concession. The shared thesis is that exclusion creates market inefficiency, and capturing overlooked alpha is a performance imperative, not a diversity mandate.
GP development as a value lever
Illumen works hands-on with portfolio managers through IllumenIQ to install bias-reduction practices. Colibrí's research equips GPs with empirical data to strengthen their fundraising positioning and portfolio construction discipline. Both invest in the manager, not just the fund.
LP education as a structural lever
Colibrí's white paper directly addresses LP due diligence, AUM screening, and enterprise risk assessment. Illumen's LP base (foundations, family offices, institutional allocators) is exactly the audience that can act on these findings to shift capital allocation patterns.
These Pair With Any Event Format
Regardless of which event option(s) Illumen selects, the following two programs can run alongside them to extend the impact of the partnership beyond a single activation.
GP Fieldwork Session
Virtual or In-Person · Illumen Portfolio ManagersA dedicated session for Illumen's portfolio managers (on-site during Milken week or virtual in the weeks following) that goes beyond the white paper headlines. This session would focus on how emerging GPs can leverage the research data in their own fundraising conversations, including the diagnostic tool Colibrí developed for emerging managers.
This slots naturally into the quarterly learning sessions Illumen already runs with their managers, and can be positioned as a resource drop during a period when many portfolio managers are going back out to fundraise.
Format
60-minute session. 20 minutes presenting key data points and fundraising implications, 15 minutes walking through the GP diagnostic tool, and 25 minutes of open Q&A and discussion.
Audience
Illumen portfolio managers who are currently fundraising or preparing to go out to market. Especially relevant for Fund II and Fund III managers who need to articulate track record and configuration advantage to new LPs.
Cost
No cost for virtual delivery. If incorporated into a Milken-week in-person session, cost limited to space and refreshments. Colibrí provides all content and diagnostic tool access at no charge.
Deliverable
Post-session resource package for managers: key data points for pitch decks, the GP diagnostic tool, and a one-pager on configuration-performance fit that managers can reference in LP conversations.
Research Co-Distribution
Ongoing · Multi-ChannelA structured research distribution partnership that extends beyond Milken week. This involves co-branded or Illumen-authored distribution of Colibrí research findings through Illumen's existing channels, reaching both the GP portfolio and the LP base with targeted messaging for each audience.
IllumenIQ Post
A dedicated post within the IllumenIQ platform highlighting the research findings and connecting them to bias-reduction practices. Authored by Illumen's team with Colibrí-provided data. Reaches all Illumen portfolio managers.
LP Newsletter Feature
A feature in Illumen's LP newsletter presenting key findings from the white paper, framed around the cost of exclusion and the performance case for emerging managers. Reaches Illumen's LP base of foundations, family offices, and institutional allocators.
Diagnostic Tool Distribution
Sharing both the GP and LP diagnostic tools through Illumen's channels. The GP tool helps managers self-assess configuration discipline. The LP tool helps allocators evaluate whether their emerging manager programs are performance-driven.
Cost
No cost. Colibrí provides all content, data highlights, and diagnostic tool access. Illumen provides distribution infrastructure and audience. Both organizations benefit from expanded reach and credibility.
Mutual Value Creation
Empirical ammunition for your thesis
Independent, peer-quality research that validates Illumen's investment thesis with hard data. The 7.2pp IRR finding and $72M foregone returns framing give Illumen's team concrete numbers to use in LP conversations and portfolio manager coaching.
GP retention and fundraising support
Portfolio managers who are going back out to fundraise get a research-backed toolkit that directly addresses LP objections around risk, track record, and fund size. This strengthens Illumen's value-add to portfolio managers beyond capital.
Direct channel to target audiences
Illumen's GP portfolio and LP base are exactly the stakeholders who need to see and act on this research. Distribution through Illumen's trusted channels reaches allocators and managers who are already predisposed to the thesis.
Milken-week visibility and credibility
Co-hosting with Illumen during Milken week positions Colibrí Institute alongside an established institutional investor. This is particularly valuable as the Institute builds its public profile and expands its research distribution footprint.
Diagnostic Tools
As part of any activation option, Colibrí is prepared to share both diagnostic tools at no charge for distribution to Illumen's portfolio managers and LP network.
GP Diagnostic Tool
A self-assessment for emerging managers that evaluates portfolio configuration discipline, including check size policy, portfolio breadth, stage focus, and alignment with their resource environment. Designed to surface early signals of strategic fit or misalignment before performance data is available.
LP Diagnostic Tool
An assessment for institutional allocators to evaluate whether their emerging manager program is built around performance objectives or compliance mandates. Covers screening criteria, enterprise risk assessment methodology, integration with core allocations, and graduation pathways.
Building Toward a Longer Partnership
Milken is the starting point, not the finish line. There are two longer-horizon collaboration opportunities worth exploring together.
2027 Impact Experience
We would be honored to explore what a future Impact Experience could look like with Colibrí as a research provocateur, potentially timed to the release of our second white paper on risk-adjusted returns for emerging managers.
Research Collaboration
Illumen's partnership with Stanford SPARQ and Colibrí's empirical work on VC fund performance represent complementary research agendas. We would welcome a conversation about where our work might intersect or build on each other in future cycles.
Build the right room together.
Colibrí Institute and Illumen Capital are peers in this ecosystem, and this activation is stronger because of it. Colibrí brings the first empirical dataset documenting emerging manager outperformance across a 25-year, 2,471-fund sample, and a growing network of LP, GP, and institutional relationships. Illumen brings one of the most trusted platforms in research-driven emerging manager investing, a portfolio of fund managers who are exactly who this data is for, and an LP base of foundations, family offices, and institutional allocators who can act on it. Together, we build a room that commands attention, not because of who is hosting, but because of what is in the room.
None of this is fixed. We would love to get on a call to think through format, structure, guest mix, and which additional partners might make sense alongside us. Consider this a first draft of a conversation.